McKesson Corporation
McKesson Corporation (MCK) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · MCK · as of Jun 8, 2026
Key Statistics
Explore McKesson Corporation Data
mck stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 31 · Buy rate: 80.6%
The MCK analyst consensus is Buy, based on ratings from 31 Wall Street analysts over the past 3 months. The average 12-month price target is $994.86, representing +28.26% upside from the current price of $775.66.
Competitors & Peers
mck competitorsMCK
BMY
CAH
COR
CVS
GSKStock Performance
Full HistoryAbout McKesson Corporation
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Presc…
what is mckesson corporation · mck stock overview · mckesson corporation company profile · who is mckesson corporation ceo · mck NYSE · mckesson corporation headquarters · mckesson corporation business segments
About Stock Overview & Key Data
McKesson Corporation (MCK) is a Healthcare company in the Medical - Distribution industry, listed on NYSE since Nov 10, 1994. As of the latest trading session, MCK stock price is $775.66, with a market capitalization of $93.2B. The stock has returned +9.52% over the past 12 months and -5.44% year-to-date.
According to 31 Wall Street analysts, the consensus rating for McKesson Corporation stock is Buy, with an average 12-month price target of $994.86. In fiscal year 2026, McKesson Corporation reported revenue of $403.4B and net income of $4.8B. For detailed data — including McKesson Corporation revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, McKesson Corporation (MCK) stock price is $775.66. The stock is traded on NYSE under the ticker symbol MCK. The 52-week range is $637.00 – $999.00.